BSX
Boston Scientific Corp
NYSE: BSX · HEALTHCARE · MEDICAL DEVICES
$57.61
+0.80% today
Updated 2026-04-29
Market cap
$85.62B
P/E ratio
24.10
P/S ratio
4.15x
EPS (TTM)
$2.39
Dividend yield
—
52W range
$56 – $110
Volume
15.7M
Boston Scientific Corp (BSX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.30%
Operating margin
21.50%
ROE
12.40%
ROA
5.98%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $7.82B | $-3.58B | 65.00% | 15.79% | -45.74% |
| 2007 | $8.36B | $-495.00M | 64.60% | 14.12% | -5.92% |
| 2008 | $8.05B | $-2.04B | 63.23% | 16.09% | -25.29% |
| 2009 | $8.19B | $-1.02B | 63.21% | 15.91% | -12.52% |
| 2010 | $7.81B | $-1.06B | 61.32% | 13.75% | -13.64% |
| 2011 | $7.62B | $441.00M | 61.43% | 14.73% | 5.79% |
| 2012 | $7.25B | $-4.07B | 62.91% | 13.71% | -56.12% |
| 2013 | $7.14B | $-121.00M | 63.49% | 12.19% | -1.69% |
| 2014 | $7.38B | $-119.00M | 62.17% | 11.45% | -1.61% |
| 2015 | $7.48B | $-239.00M | 61.04% | 10.57% | -3.20% |
| 2016 | $8.39B | $347.00M | 63.71% | 14.74% | 4.14% |
| 2017 | $9.05B | $104.00M | 64.89% | 16.85% | 1.15% |
| 2018 | $9.82B | $1.67B | 65.94% | 17.68% | 17.01% |
| 2019 | $10.73B | $4.70B | 64.08% | 15.95% | 43.78% |
| 2020 | $9.91B | $-82.00M | 56.25% | 6.06% | -0.83% |
| 2021 | $11.89B | $1.04B | 62.76% | 16.17% | 8.75% |
| 2022 | $12.68B | $698.00M | 60.83% | 14.38% | 5.50% |
| 2023 | $14.24B | $1.59B | 62.02% | 15.32% | 11.19% |
| 2024 | $16.75B | $1.85B | 61.31% | 15.73% | 11.07% |
| 2025 | $20.07B | $2.89B | 69.01% | 19.78% | 14.38% |